Skip to main content
. Author manuscript; available in PMC: 2021 May 4.
Published in final edited form as: Mol Pharm. 2020 Apr 8;17(5):1527–1537. doi: 10.1021/acs.molpharmaceut.9b01227

Figure 3.

Figure 3.

Plasma (A) and brain (B) concentrations of valsartan following oral administration (0.2 mg/kg) to WT (closed circles) and APP/PS1 mice (open squares). ^ Brain concentrations of valsartan were only detectable in one WT mouse at 1 h and were undetectable at later time points. # Brain concentrations of valsartan were only detectable in two APP/PS1 mice at 2 h and were undetectable at later time points. Data are presented as mean ± SD (n=3).